NPHC - Nutra Pharma Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue168.356291.302594.505
Cost of Revenue223.00465.805114.3
Gross Profit-54.648225.497480.205
Operating Expenses
Research Development---
Selling General and Administrative1,988.8685,991.632,682.479
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-2,043.516-5,766.133-2,202.274
Income from Continuing Operations
Total Other Income/Expenses Net-1,110.312808.699-202.607
Earnings Before Interest and Taxes-3,153.828-4,957.434-2,404.881
Interest Expense293.785434.547128.104
Income Before Tax-3,447.613-5,391.981-2,532.985
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-3,447.613-5,391.981-2,532.985
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-3,447.613-5,391.981-2,532.985
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-3,447.613-5,391.981-2,532.985